The Fifth International Conference on Chemicals Management (ICCM5) concluded on 30 September in Bonn, Germany, by adopting “a comprehensive global framework that sets concrete targets and guidelines for key sectors across the entire lifecycle of chemicals”.

The new Global Framework on Chemicals is based around 28 targets and outlines a roadmap for countries and stakeholders to address the lifecycle of chemicals, including products and waste, collaboratively. It calls, among other things, for the:

* Prevention of the illegal trade and trafficking of chemicals and waste

At its latest Capital Markets Day on 27 September 2023, Arkema revealed its plans to strengthen its decarbonisation initiatives as well as its financial targets. This followed the recent validation of Arkema’s emissions reduction plan by the Science-Based Targets Initiatives.

The American Chemistry Council (ACC) has launched an initiative called ‘Chemistry Creates, America Competes’. This comes in direct response to what it regards as the Biden administration’s ‘regulatory overreach’ and aims to help the administration and Congress understand the importance of ‘American Chemistry’.

A study by the independent Institute for Material Testing has confirmed an earlier report by the FILK Institute that biocides used in the preservation of leather intermediates do not migrate out of the finished leather articles, according to Lanxess, which commissioned it.

The European Chemicals Agency (ECHA) has amended the Prior Informed Consent (PIC) Regulation, EU 64/2012, to add 27 pesticides and eight industrial chemicals into Annex I, bringing the total to 295. As a result, EU exporters are now required to notify their intentions to export them from 1 November onwards.

Members of the Sustainable Markets Initiative Health Systems Task Force have published an open letter to suppliers in the supply chain, asking them to commit to joining the initiative and working towards climate and sustainability targets. The CEOs of AstraZeneca, GSK, Merck& Co., Novo Nordisk, Sanofi and Samsung Biologics, and the chairman of Roche all signed it.

The independent Science-Based Targets Initiative (SBTi) has confirmed that Evonik’s greenhouse gas emission reduction targets are in line with the Paris Agreement on Climate Change. This seeks to limit global warming to well below 2°C.